Donor-specific Transplantation Tolerance: the Paradoxical Behavior of CD4+CD25+ T Cells

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2004 Jun 26

PMID 15218097

Citations 38

Authors

Luis Graca

Alain Le Moine

Chun-Yen Lin

Paul J Fairchild

Stephen P Cobbold

Herman Waldmann

Affiliations

Soon will be listed here.

Abstract

To investigate the antigen specificity of regulatory T cells capable of preventing transplant rejection, we have developed two different strategies to achieve tolerance to fully mismatched skin grafts in euthymic mice. A combination of nondepleting Abs targeting CD4, CD8, and CD154 (CD40 ligand) induces dominant transplantation tolerance to fully mismatched skin allografts. Such tolerance is antigen-specific, mediated by regulatory T cells, and can be extended through linked suppression to naïve lymphocytes. The same protocol, when combined with allogeneic bone marrow, enables the development of mixed hematopoietic chimerism and deletional tolerance. Although we cannot exclude that some regulatory T cells may persist in chimeric mice, these cells are insufficient to mediate linked suppression. CD4(+)CD25(+) T cells, whether taken from naïve mice or from mice tolerized through either treatment protocol, were always able to prevent rejection of skin grafts by naïve CD4(+) T cells, and did so with no demonstrable specificity for the tolerizing donor antigens. Such data question whether CD4(+)CD25(+) regulatory T cells alone can account for the antigen specificity of dominant transplantation tolerance.

Citing Articles

Progress in islet xenotransplantation: Immunologic barriers, advances in gene editing, and tolerance induction strategies for xenogeneic islets in pig-to-primate transplantation.

Eisenson D, Hisadome Y, Santillan M, Yamada K Front Transplant. 2024; 1.

PMID: 38390384 PMC: 10883655. DOI: 10.3389/frtra.2022.989811.

CD3e-immunotoxin spares CD62L Tregs and reshapes organ-specific T-cell composition by preferentially depleting CD3e T cells.

Kim S, Shukla R, Yu H, Baek A, Cressman S, Golconda S Front Immunol. 2022; 13:1011190.

PMID: 36389741 PMC: 9643874. DOI: 10.3389/fimmu.2022.1011190.

Antigen Specific Regulatory T Cells in Kidney Transplantation and Other Tolerance Settings.

Hu M, Rogers N, Li J, Zhang G, Wang Y, Shaw K Front Immunol. 2021; 12:717594.

PMID: 34512640 PMC: 8428972. DOI: 10.3389/fimmu.2021.717594.

Tregs and Mixed Chimerism as Approaches for Tolerance Induction in Islet Transplantation.

Pathak S, Meyer E Front Immunol. 2021; 11:612737.

PMID: 33658995 PMC: 7917336. DOI: 10.3389/fimmu.2020.612737.

Donor-Derived Myeloid Heme Oxygenase-1 Controls the Development of Graft-Versus-Host Disease.

Spilleboudt C, De Wilde V, Lewalle P, Cabanne L, Leclerc M, Beckerich F Front Immunol. 2021; 11:579151.

PMID: 33537027 PMC: 7849683. DOI: 10.3389/fimmu.2020.579151.

References

Wekerle T, Kurtz J, Ito H, Ronquillo J, Dong V, Zhao G . Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med. 2000; 6(4):464-9. DOI: 10.1038/74731. View

Davies J, Leong L, Mellor A, Cobbold S, Waldmann H . T cell suppression in transplantation tolerance through linked recognition. J Immunol. 1996; 156(10):3602-7. View

Durham M, Bingaman A, Adams A, Ha J, Waitze S, Pearson T . Cutting edge: administration of anti-CD40 ligand and donor bone marrow leads to hemopoietic chimerism and donor-specific tolerance without cytoreductive conditioning. J Immunol. 2000; 165(1):1-4. DOI: 10.4049/jimmunol.165.1.1. View

Annacker O, Barbosa T, Cumano A, Bandeira A . CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J Immunol. 2001; 166(5):3008-18. DOI: 10.4049/jimmunol.166.5.3008. View

Maloy K, Powrie F . Regulatory T cells in the control of immune pathology. Nat Immunol. 2001; 2(9):816-22. DOI: 10.1038/ni0901-816. View

Kingsley C, Karim M, Bushell A, Wood K . CD25+CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol. 2002; 168(3):1080-6. DOI: 10.4049/jimmunol.168.3.1080. View

Taylor P, Lees C, Blazar B . The infusion of ex vivo activated and expanded CD4(+)CD25(+) immune regulatory cells inhibits graft-versus-host disease lethality. Blood. 2002; 99(10):3493-9. DOI: 10.1182/blood.v99.10.3493. View

Graca L, Thompson S, Lin C, Adams E, Cobbold S, Waldmann H . Both CD4(+)CD25(+) and CD4(+)CD25(-) regulatory cells mediate dominant transplantation tolerance. J Immunol. 2002; 168(11):5558-65. DOI: 10.4049/jimmunol.168.11.5558. View

Shevach E . CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol. 2002; 2(6):389-400. DOI: 10.1038/nri821. View

10.

Hoffmann P, Ermann J, Edinger M, Fathman C, Strober S . Donor-type CD4(+)CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation. J Exp Med. 2002; 196(3):389-99. PMC: 2193938. DOI: 10.1084/jem.20020399. View

11.

Cohen J, Trenado A, Vasey D, Klatzmann D, Salomon B . CD4(+)CD25(+) immunoregulatory T Cells: new therapeutics for graft-versus-host disease. J Exp Med. 2002; 196(3):401-6. PMC: 2193933. DOI: 10.1084/jem.20020090. View

12.

Wekerle T, Kurtz J, Bigenzahn S, Takeuchi Y, Sykes M . Mechanisms of transplant tolerance induction using costimulatory blockade. Curr Opin Immunol. 2002; 14(5):592-600. DOI: 10.1016/s0952-7915(02)00378-3. View

13.

van Maurik A, Herber M, Wood K, Jones N . Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy. J Immunol. 2002; 169(10):5401-4. DOI: 10.4049/jimmunol.169.10.5401. View

14.

Barthlott T, Kassiotis G, Stockinger B . T cell regulation as a side effect of homeostasis and competition. J Exp Med. 2003; 197(4):451-60. PMC: 2193859. DOI: 10.1084/jem.20021387. View

15.

Chen Z, Cobbold S, Waldmann H, Metcalfe S . Amplification of natural regulatory immune mechanisms for transplantation tolerance. Transplantation. 1996; 62(9):1200-6. DOI: 10.1097/00007890-199611150-00002. View

16.

Wong W, Morris P, Wood K . Pretransplant administration of a single donor class I major histocompatibility complex molecule is sufficient for the indefinite survival of fully allogeneic cardiac allografts: evidence for linked epitope suppression. Transplantation. 1997; 63(10):1490-4. DOI: 10.1097/00007890-199705270-00020. View

17.

Bemelman F, Honey K, Adams E, Cobbold S, Waldmann H . Bone marrow transplantation induces either clonal deletion or infectious tolerance depending on the dose. J Immunol. 1998; 160(6):2645-8. View

18.

Wise M, Bemelman F, Cobbold S, Waldmann H . Linked suppression of skin graft rejection can operate through indirect recognition. J Immunol. 1998; 161(11):5813-6. View

19.

Honey K, Cobbold S, Waldmann H . CD40 ligand blockade induces CD4+ T cell tolerance and linked suppression. J Immunol. 1999; 163(9):4805-10. View

20.

Wood K, Sakaguchi S . Regulatory T cells in transplantation tolerance. Nat Rev Immunol. 2003; 3(3):199-210. DOI: 10.1038/nri1027. View